Liver transplantation and peri- operative changes to renal function
Authors:
E. Kieslichová 1; O. Schück 2; I. Smrčková 3; J. Granátová 5; J. Skibová 1; D. Merta 1; P. Trunečka 4
Authors‘ workplace:
Klinika anesteziologie, resuscitace a intenzivní péče IKEM Praha, přednostka MU Dr. Eva Kieslichová
1; Klinika nefrologie IKEM Praha, přednosta prof. MU Dr. Ondřej Viklický, CSc.
2; Oddělení klinické biochemie IKEM Praha, přednosta prof. MU Dr. Antonín Jabor, CSc.
3; Transplantcentrum IKEM Praha, přednosta prim. MU Dr. Pavel Trunečka, CSc.
4; Oddělení klinické biochemie Fakultní Thomayerovy nemocnice Praha, prim. MU Dr. Zora Hamrlová
5
Published in:
Vnitř Lék 2009; 55(12): 1126-1134
Category:
Original Contributions
Overview
The aim of the study:
Was to analyze in detail perioperative changes of renal function during orthotopic liver transplantation (OLT) and to identify risk factors, that were associated with the need of renal replacement therapy (RRT) during the first week after liver transplantation. Methods: Prospective study of 50 consecutive patients undergoing OLT was performed. Selected laboratory and clinical parameters were monitored prior to the procedure, after reperfusion, at the end of the procedure, and at 12 hours after the procedure. In the first post‑transplant week, necessity to use RRT in the presence of acute kidney injury was monitored and the analysis of risk factors for the need for RRT was performed. Patient survival, graft function, need for dialysis and selected laboratory parameters were assessed at one year post‑transplant. Results: During OLT, there was an increase in Scr and Surea, which persisted as late as 12 hours post‑transplant. There was a decrease in Ucr and Uurea and an increase in SNa and SK. During the procedure any increase in Scyst were observed, increase the values were recorded 12 hours after surgery. Sbili level decreased. There was a rise in the urinary levels of total protein, albumin and β2-microglobulin. Uprot/ Ucr increased significantly after reperfusion, with a peak after the procedure. At 12 hours after the procedure, there was a decrease in Uprot/ Ucr, but the values were still many times higher than those seen preoperatively. RRT was necessary in 14% cases. Risk factors for acute kidney injury requiring RRT included a higher APACHE score, higher BMI, higher preoperative Scr and Surea, hepatorenal syndrome pretransplant, blood loss and intraoperative hemodynamic instability, postoperative complications and dysfunction of the liver graft. One year after OLT, there was no difference in followed laboratory values between patients requiring postoperative RRT and others; no patient was treated with dialysis. Conclusion: OLT has a major impact on glomerular and tubular renal functions. Our data suggest that patients surviving acute renal injury treated with RRT in the early postoperative period have a high chance of restoring renal function. A sensitive marker of renal injury during OLT seems to be perioperative proteinuria.
Key words:
liver transplantation – acute kidney injury – renal replacement therapy
Sources
1. Pham PT, Pham PC, Wilkinson AH. The kidney in liver transplantation. Clin Liver Dis 2000; 4: 576– 590.
2. Neau- Cransac M, Morel D, Merville P et al. Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawal. Clin Transplant 2002; 16: 368– 373.
3. Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I. Liver Transpl 2002; 8: 91– 109.
4. Gines P, Arroyo V, Rodes J. Renal fuction in cirrhosis: pathophysiology and clinical features. In: Zakim D, Boyer TD (eds). Hepatology: a textbook of liver disease. 4th ed. Philadelphia: Elsevier 2003: 497– 516.
5. Ginès P, Guevara M, Arroyo V. Hepatorenal syndrome. Lancet 2003; 362: 1819– 1827.
6. Marik PE, Wood K, Starzl T. The course of type 1 hepato- renal syndrome post liver transplantation. Nephrol Dial Transpl 2006; 21: 478– 482.
7. Yalavarthy R, Edelstein CL, Teitelbaum I. Acute renal failure and chronic kidney disease following liver transplantation. Hemodial Int 2007; 11 (Suppl 3): 7– 12.
8. Chuang FR, Lin CC, Wang PH et al. Acute renal failure after cadaveric related liver transplantation. Transplant Proc 2004; 36: 2328– 2330.
9. Junge G, Schewior LV, Kohler S et al. Acute renal failure after liver transplantation: incidence, etiology, therapy, and outcome. Transplant Proc 2006; 38: 723– 724.
10. Gainza FJ, Valdivieso A, Quintanilla N et al. Evaluation of acute renal failure in the liver transplantation period. Incidence and impact. Transplant Proc 2002; 34: 250– 251.
11. Bellomo R, Ronco C, Kellum JA et al. Acute Dialysis Quality Initiative Workgroup. Acute renal failure – definition, outcome, measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative Group. Crit Care 2004; 8: R204– R212.
12. Reddy VG. Prevention of postoperative acute renal failure. J Postgrad Med 2002; 48: 64– 70.
13. Grande L, Rimola A, Cugat E et al. Effect of venovenous bypass on perioperative renal function in liver transplantation: result of a randomized, controlled trial. Hepatology 1996; 23: 1418– 1428.
14. Reddy K, Mallet S, Peachey T. Venovenous bypass in orthotopic liver transplantation: time for rethink? Liver Transplant 2005; 11: 741– 749.
15. Contreras G, Garces G, Quartin AA et al. An epidemiologic study of early renal replacement therapy after orthotopic liver transplantation. J Am Soc Nephrol 2002; 13: 228– 233.
16. Cabezuelo JB, Ramirez P, Acosta F et al. Does the surgical technique used (standard vs Piggy Back) have an effect on development of early acute renal failure after orthotopic liver transplantation? Transplant Proc 2003; 35: 1913– 1914.
17. Cabezuelo JB, Ramírez P, Ríos A et al. Risk factors of acute renal failure after liver transplantation. Kidney Int 2006; 69: 1073– 1080.
18. Lima EQ, Zanetta DM, Castro I et al. Risk factors for development of acute renal failure after liver transplantation. Ren Fail 2003; 25: 553– 560.
19. Mazzachi BC, Peake MJ, Ehrhardt V. Reference range and method comparison studies for enzymatic and Jaffé creatinine assays in plasma and serum and early morning urine. Clin Lab 2000; 46: 53– 55.
20. Schroeder RA, Collins BH, Tuttle- Newhall E et al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothoracic Vasc Anesth 2004; 18: 438– 441.
21. Nankivell BJ, Borrows RJ, Fung CL et al. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 2004; 78: 557– 565.
22. Gonwa TA, Mai ML, Melton LB et al. Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno‑venous hemodialysis. Transplantation 2001; 71: 1424– 1428.
23. Wyatt CM, Arons RR. The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation 2004; 78: 1351– 1355.
24. Sanchez EQ, Gonwa TA, Levy MF et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004; 78: 1048– 1054.
25. Faenza S, Bernardi E, Cimatti M et al. Acute renal failure after liver transplantation in MELD era. Transplant Proc 2007; 39: 1945– 1946.
26. O’Riordan A, Wong W, McQuillan R et al. Acute renal disease, as defined by the RIFLE criteria, post – liver transplantation. Am J Transplant 2007; 7: 168– 176.
27. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003; 9: 741– 747.
28. Faenza S, Santoro A, Mancini E et al. Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation. Transplant Proc 2006; 38: 1141– 1142.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2009 Issue 12
Most read in this issue
- Pre‑eclampsia from the perspective of inter- professional collaboration
- The programme of managed ambulatory rehabilitation for patients after heart valve defect surgery
- The complexity of interactions of the tumour growth process
- Symmetrical phlebothrombosis of lower extremities resulting from congenital malformation of vena cava inferior